A multidrug-resistance protein (MRP)-like transmembrane pump is highly expressed by resting murine T helper (Th) 2, but not Th1 cells, and is induced to equal expression levels in Th1 and Th2 cells after antigenic stimulation in vivo.
暂无分享,去创建一个
M. Lohoff | E. Schmitt | S. Cole | R. Deeley | P. Rohwer | F. Sommer | S. Prechtl | B. Stride | M. Roellinghoff | G. Gradehandt
[1] S. Cole,et al. Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter. , 1996, Molecular pharmacology.
[2] S. Cole,et al. ATP-dependent 17-Estradiol 17-(-D-Glucuronide) Transport by Multidrug Resistance Protein (MRP) , 1996, The Journal of Biological Chemistry.
[3] S Miltenyi,et al. Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[4] H. Macdonald,et al. Heterogeneity in P‐glycoprotein (multidrug resistance) activity among murine peripheral T cells: Correlation with surface phenotype and effector function , 1994, European journal of immunology.
[5] D. Hipfner,et al. Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. , 1994, Cancer research.
[6] D. Keppler,et al. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. , 1994, The Journal of biological chemistry.
[7] M. Lohoff,et al. Demonstration of organic anion transport in T lymphocytes. L-lactate and fluo-3 are target molecules. , 1994, Journal of immunology.
[8] C. Meijer,et al. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. , 1994, Cancer research.
[9] W. Dalton,et al. Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. , 1994, Cancer research.
[10] R. Balderas,et al. Vβ gene repertoires in T cells expanded in local self‐healing and lethal systemic murine cutaneous leishmaniasis , 1994 .
[11] D. Hipfner,et al. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. , 1994, Cancer research.
[12] A. Duncan,et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.
[13] A. Pourtier-Manzanedo,et al. Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative. , 1991, Experimental cell research.
[14] M. Betz,et al. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. , 1991, Journal of immunology.
[15] B. Huber,et al. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation , 1990, The Journal of experimental medicine.
[16] M. Lohoff,et al. Different response of TH1 cells for stimulation with anti‐CD3 antibodies , 1990, European journal of immunology.
[17] J. Snick,et al. Tcgfiii/p40 is produced by naive murine cd4+ t cells but is not a general t cell growth factor* , 1989 .
[18] E. Puré,et al. Changes in CD45 isoform expression accompany antigen-induced murine T-cell activation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[19] M. Lohoff,et al. Polyclonal B-cell stimulation by L3T4+ T cells in experimental leishmaniasis , 1988, Infection and immunity.
[20] J. Coligan,et al. Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation. , 1988, Journal of immunology.
[21] E. Rüde,et al. The specificity of the interaction between the agretope of an antigen and an Ia-molecule can depend on the T cell clonotype. , 1988, Molecular immunology.
[22] F. Di Virgilio,et al. Fura-2 secretion and sequestration in macrophages. A blocker of organic anion transport reveals that these processes occur via a membrane transport system for organic anions. , 1988, Journal of immunology.
[23] H. Karasuyama,et al. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors , 1988, European journal of immunology.
[24] H. Macdonald,et al. Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. , 1987, Journal of immunology.
[25] D. Alberts,et al. Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein. , 1986, Cancer research.
[26] C. Bogdan,et al. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice. , 1986, Journal of immunology.
[27] R. Tsien,et al. A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.
[28] E. Shevach,et al. The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells. , 1984, Journal of immunology.
[29] C. Janeway,et al. Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. , 1984, Journal of immunology.
[30] I Lefkovits,et al. Limiting dilution analysis of the cells of immune system I. The clonal basis of the immune response. , 1984, Immunology today.
[31] D. Cantrell,et al. The interleukin-2 T-cell system: a new cell growth model. , 1984, Science.
[32] J. Riordan,et al. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. , 1983, Science.
[33] I. Weissman,et al. A cell-surface molecule involved in organ-specific homing of lymphocytes , 1983, Nature.
[34] R. Locksley,et al. The regulation of immunity to Leishmania major. , 1995, Annual review of immunology.
[35] M. Barrand,et al. Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein. , 1993, European journal of cancer.
[36] V. Ling,et al. Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy. , 1990, Advances in pharmacology.
[37] Andreas Radbruch,et al. High gradient magnetic cell separation with MACS. , 1990, Cytometry.
[38] J. Endicott,et al. The biochemistry of P-glycoprotein-mediated multidrug resistance. , 1989, Annual review of biochemistry.
[39] V. Ling,et al. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies , 1985, Nature.
[40] V. Ling,et al. Hoechst 33342 dye uptake as a probe of membrane permeability changes in mammalian cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.